» Articles » PMID: 39086952

Case Report: Variability in Clinical Manifestations Within a Family with Incontinentia Pigmenti

Abstract

Diagnosing skin diseases in children can be a complex interdisciplinary problem. Incontinentia pigmenti (IP), also known as Bloch-Sulzberger syndrome, is a rare hereditary genodermatosis related to a mutation in the gene. We present a family case of IP described from the perspective of various specialists, including dermatologists, oncologists, geneticists, dentists, and trichologists. The peculiarity of this case is the development of squamous cell carcinoma (SCC) on the shin of a 10-year-old female patient with IP. The patient had a positive family history: her mother and two sisters also displayed clinical manifestations of IP with involvement of skin, teeth and hair. The presence of exons 4-10 deletion in the gene in all affected females was confirmed by detailed genetic evaluation using long-range PCR, and also high degree of X-chromosome inactivation skewing was demonstrated. The family underwent a comprehensive examination and was followed up for 2 years with successful symptomatic treatment of dermatologic manifestations. Recommendations were also made regarding dental and hair problems. By the end of the follow-up period, patients had stabilized, with the exception of a 36-year-old mother who developed generalized morphea. The study demonstrates the varying expressiveness of clinical symptoms among family members and emphasizes the importance of timely diagnosis for effective management of patients with IP.

References
1.
van Hogerlinden M, Rozell B, Ahrlund-Richter L, Toftgard R . Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 1999; 59(14):3299-303. View

2.
Fusco F, Valente V, Fergola D, Pescatore A, Lioi M, Ursini M . The Incontinentia Pigmenti Genetic Biobank: study design and cohort profile to facilitate research into a rare disease worldwide. Eur J Hum Genet. 2019; 27(10):1509-1518. PMC: 6777495. DOI: 10.1038/s41431-019-0451-0. View

3.
Ascierto P, Schadendorf D . Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma. J Immunother Cancer. 2022; 10(12). PMC: 9716987. DOI: 10.1136/jitc-2022-005082. View

4.
Chen A, Chen K . Dental treatment considerations for a pediatric patient with incontinentia pigmenti (Bloch-Sulzberger syndrome). Eur J Dent. 2017; 11(2):264-267. PMC: 5502577. DOI: 10.4103/ejd.ejd_95_17. View

5.
Nwabudike L, Tatu A . Reply to Gambichler T et al.: Altered epigenetic pathways and cell cycle dysregulation in healthy appearing skin of patients with koebnerized squamous cell carcinomas following skin surgery. J Eur Acad Dermatol Venereol. 2018; 33(1):e3-e4. DOI: 10.1111/jdv.15084. View